Strontium ranelate (Protos) for postmenopausal osteoporosis Strontium ranelate (Protos) for postmenopausal osteoporosis

Published 2010-04-23 00:00:00

New information relevant to this topic has become available since this RADAR review was published in November 2007.

Links to some relevant resources are provided below.

Category

Title

Date

TGA-approved Product Information

Strontium ranelate (Protos), last amended 18 July 2008

July 2008

Australian guidelines

Clinical guideline for the prevention and treatment of osteoporosis in post-menopausal women and older men

February 2010

Australian Adverse Drug Reactions Bulletin

Severe skin reactions and venous thromboembolism with strontium ranelate (Protos) (Volume 27, Number 3)

June 2008

Other NPS publications about osteoporosis drugs

 

 

Published 2010-04-23 00:00:00

The information contained in this material is derived from a critical analysis of a wide range of authoritative evidence. Any treatment decisions based on this information should be made in the context of the clinical circumstances of each patient.

RSS FeedRSS feed
This site complies to the HONcode standard for trustworthy health information: verify here.
Health Insite Logo This website is certified by Health On the Net Foundation. Click to verify.